Novo Nordisk recognizes that some patients find it difficult to pay for healthcare, including insulin. As such, the company remains committed to reducing the burden of out-of-pocket costs, helping transform the complex pricing system, and fostering better pricing predictability. Novo Nordisk continually reviews and revises our offerings and works with diverse stakeholders to create solutions for differing patient needs.

Explore our commitment over the years

Partnered with Walmart to create a Human Insulin Program

2000
For over 2 decades, ReliOn Novolin® has been available in the market for under $25 per vial
2000

Partnered with Walmart to create a Human Insulin Program

For over 2 decades, ReliOn Novolin® has been available in the market for under $25 per vial

Global access to care strategy

2001
Established the global access to care strategy, a ground-breaking policy to lower the cost of insulin in low-income countries
2001

Global access to care strategy

Established the global access to care strategy, a ground-breaking policy to lower the cost of insulin in low-income countries

Patient Assistance Program

2003
Launched our Patient Assistance Program to offer free diabetes products to eligible low-income patients
2003

Patient Assistance Program

Launched our Patient Assistance Program to offer free diabetes products to eligible low-income patients

Limit price increases

2016
Pledged to limit any potential list price increases to single digits annually
2016

Limit price increases

Pledged to limit any potential list price increases to single digits annually

Access to Insulin Commitment

2016
Initiated the Access to Insulin Commitment designed to lower the ceiling price and include humanitarian relief settings, while guaranteeing low-priced human insulin for patients in underprivileged regions of the world for many years to come
2016

Access to Insulin Commitment

Initiated the Access to Insulin Commitment designed to lower the ceiling price and include humanitarian relief settings, while guaranteeing low-priced human insulin for patients in underprivileged regions of the world for many years to come

Novo Nordisk Novolin®

2017
Worked with CVS to make Novo Nordisk Novolin® available to patients for $25 per vial
2017

Novo Nordisk Novolin®

Worked with CVS to make Novo Nordisk Novolin® available to patients for $25 per vial

NovoCare®

2017
Launched NovoCare® , a single destination for all branded savings/copay offers, other affordability programs and educational resources
2017

NovoCare®

Launched NovoCare® , a single destination for all branded savings/copay offers, other affordability programs and educational resources

ReliOn Novolin®

2018
Made ReliOn Novolin® insulin pens available at Walmart
2018

ReliOn Novolin®

Made ReliOn Novolin® insulin pens available at Walmart

Immediate Supply

2020
Established Immediate Supply: A one-time free short-term supply of insulin (up to 3 vials or 2 packs of pens) to eligible patients at risk of rationing
2020

Immediate Supply

Established Immediate Supply: A one-time free short-term supply of insulin (up to 3 vials or 2 packs of pens) to eligible patients at risk of rationing

COVID-19 Patient Assistance Program

2020
Created the COVID-19 Patient Assistance Program: Offers 90 days of free insulin to eligible patients who lost healthcare coverage due to COVID-19 job loss. *Program ended 12/31/2022
2020

COVID-19 Patient Assistance Program

Created the COVID-19 Patient Assistance Program: Offers 90 days of free insulin to eligible patients who lost healthcare coverage due to COVID-19 job loss. *Program ended 12/31/2022

Unbranded Biologics

2020
Introduced unbranded biologics, Insulin Aspart and Insulin Aspart Protamine/Insulin Aspart available at 50% off the list price of NovoLog® and NovoLog® Mix 70/30
2020

Unbranded Biologics

Introduced unbranded biologics, Insulin Aspart and Insulin Aspart Protamine/Insulin Aspart available at 50% off the list price of NovoLog® and NovoLog® Mix 70/30

ReliOn NovoLog® and NovoLog® Mix 70/30

2021
Launched ReliOn NovoLog® and NovoLog® Mix 70/30 available at Walmart
2021

ReliOn NovoLog® and NovoLog® Mix 70/30

Launched ReliOn NovoLog® and NovoLog® Mix 70/30 available at Walmart

Unbranded Biologic

2022
Made unbranded biologic, Insulin Degludec available at 65% off the list price of Tresiba®
2022

Unbranded Biologic

Made unbranded biologic, Insulin Degludec available at 65% off the list price of Tresiba®

MyInsulinRxTM

2023
Created MyInsulinRxTM : A monthly supply of any combination of Novo Nordisk insulin products for eligible patients (up to 3 vials or 2 packs of FlexPen® /FlexTouch® /PenFill® pens) for $35
2023

MyInsulinRxTM

Created MyInsulinRxTM : A monthly supply of any combination of Novo Nordisk insulin products for eligible patients (up to 3 vials or 2 packs of FlexPen® /FlexTouch® /PenFill® pens) for $35

We encourage anyone in need to go to NovoCare.com to learn more.

Copay and Patient Assistance Program offerings:

  • Copay Savings Cards: Copays for as little as $35 for several insulin products for eligible patients with commercial insurance plans

  • Patient Assistance Program: Offers free diabetes medication to people in need who meet certain eligibility criteria